Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
17 Patents
#79 in Boulder, CO
#387 in Colorado
#18,903 in US
#35,948 in the World
N30 Pharmaceuticals, Inc.
Forward Citations = 89
6 inventors:
Boulder, CO, United States of America
N30 Pharmaceuticals, Inc.
% Expired Patents = 88.2
EPO Patents = 4
Forward Citations = 89
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Xicheng David Sun (17 out of 49 patents)
Jian Qiu (15 out of 38 patents)
Jan William Wasley (9 out of 30 patents)
4. Sarah A Strong (7 out of 24 patents)
5. Gary Joseph Rosenthal (7 out of 18 patents)
6. Adam Stout (2 out of 10 patents)
17 patents:
1. 8957105 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2015-02-17),
3. 8921562 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2014-12-30),
4. 8906933 - Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists (2014-12-09),
6. 8846736 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2014-09-30),
10. 8691816 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2014-04-08),
11. 8686015 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2014-04-01),
Company Overview
N30 Pharmaceuticals, Inc. is a biotechnology company based in Boulder, Colorado, focused on developing innovative therapies for patients with serious diseases. The company specializes in the research and development of novel drug candidates, particularly in the areas of immunology and oncology. N30 aims to leverage its proprietary technologies to create transformative treatments that address unmet medical needs, enhancing patient outcomes and advancing the field of medicine.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: N30 Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/n30-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]